Results 151 to 160 of about 98,243 (192)
Some of the next articles are maybe not open access.
Chemoprevention of bilirubin encephalopathy with a nanoceutical agent
Pediatric Research, 2022Targeted rapid degradation of bilirubin has the potential to thwart incipient bilirubin encephalopathy. We investigated a novel spinel-structured citrate-functionalized trimanganese tetroxide nanoparticle (C-Mn3O4 NP, the nanodrug) to degrade both systemic and neural bilirubin loads.Severe neonatal unconjugated hyperbilirubinemia (SNH) was induced in ...
Aniruddha, Adhikari +11 more
openaire +2 more sources
Quantitative ADC in bilirubin encephalopathy
Japanese Journal of Radiology, 2013It was with great interest that we read the paper by Cece and colleagues [1] entitled ‘Diffusion-weighted imaging of patients with neonatal bilirubin encephalopathy.’ The authors conclude that quantitative apparent diffusion coefficient (ADC) measurement could be a promising marker of neonatal bilirubin encephalopathy.
Jon F, Watchko +2 more
openaire +2 more sources
The prevention of bilirubin encephalopathy
The Journal of Pediatrics, 1958Summary 1. Maternal titer values and/or apositive Coombs' test by themselves are not an indication for replacement transfusion in hemolytic disease of the newborn due to Rh incompatibility. The main emphasis should be placed on the clinical condition and early course of the newborn infant, particularly the ability to handle bilirubin. 2.
openaire +2 more sources
Clinical Features of Bilirubin Encephalopathy
Clinics in Perinatology, 1990Clinical features of bilirubin encephalopathy vary depending on the age of the infant and the degree of hyperbilirubinemia. In term infants with hyperbilirubinemia, three distinct clinical phases are apparent in the first weeks of life, and long-term consequences include extrapyramidal disturbances (particularly athetosis), hearing loss, gaze ...
A M, Connolly, J J, Volpe
openaire +2 more sources
Bilirubin encephalopathy: Changing concepts
Brain and Development, 1980This overview begins with a discussion of clinical approaches to prevent brain damage in jaundiced newborns. Results of longitudinal follow-up studies are given. The main part deals with pathogenesis, whereby bilirubin albumin binding, competition by drugs, bilirubin distribution and equilibration in the body, the increased sensitivity of the infantile
openaire +2 more sources
Acute, Severe Bilirubin Encephalopathy in a Newborn
Pediatric Emergency Care, 2004In recent years, changes in health care practices including the early discharge of newborns have transformed the management of neonatal jaundice into an outpatient problem. At the same time, there has been a resurgence in the incidence of kernicterus.
Thomas J, Mollen +2 more
openaire +2 more sources
Oxidative Phosphorylation in Experimental Bilirubin Encephalopathy
Science, 1967Mitochondria from the whole brain or cerebellum of newborn guinea pigs with experimental bilirubin encephalopathy failed to exhibit uncoupling of oxidative phosphorylation. The pigment concentrations required to initiate uncoupling in vitro are much higher than those found in the brain of neurotoxic animals.
I, Diamond, R, Schmid
openaire +2 more sources
Kernicterus (Bilirubin Encephalopathy)
1975The first report of kernicterus is generally attributed to Orth (1875), although his description is somewhat unclear and emphasizes staining of the superficial portions of brain tissue in the ventricular walls and at the hemispheric surface. The first comprehensive description of the disease was given by Schmorl (1903) who distinguished two types of ...
openaire +1 more source
Neonatal Jaundice and Prevention of Bilirubin Encephalopathy
Postgraduate Medicine, 1959The physician should be alert to the development of jaundice in the newborn infant. A high concentration of serum bilirubin may cause injury to the brain. Blood group incompatibility, infection, hepatitis or congenital anomalies of the biliary tree may result in the development of jaundice. Other less well-known factors also may be responsible.
openaire +2 more sources
International Journal of Pharmacognosy and Pharmaceutical Sciences, 2021
R Vinola +5 more
openaire +1 more source
R Vinola +5 more
openaire +1 more source

